Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform 2022-08-09 20:00
Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol® 2022-08-09 19:00
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in China 2022-08-09 17:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-004 2022-08-09 12:00
First Patient Dosed in Phase II Study of KN046 Combined with Axitinib for the First Line Treatment of Advanced Non-Small Cell Lung Cancer 2022-08-09 11:18
Sciwind Biosciences Reports Positive Interim Results from Phase 1c/2a Clinical Trial of XW003 (Ecnoglutide) in Overweight and Obese Adult Volunteers in China 2022-08-09 08:00
FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID 2022-08-09 00:00
BGI Ranks No. 1 among APAC and China Life Science Corporations for Seven Consecutive Years: 2022 Nature Index Annual Tables Revealed 2022-08-08 22:00
Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio 2022-08-08 20:00
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development 2022-08-08 12:24
BIO Asia-Taiwan 2022 concludes, marking another successful edition of the region's biggest bioindustry-focused conference and exhibition 2022-08-08 10:00
ImmVira's Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma Obtained FDA's Orphan Drug Designation 2022-08-08 08:30
Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors 2022-08-08 08:10
Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer 2022-08-08 08:00
Innovent Announces First Patient Dosed in Phase 1 Study of IBI324 (VEGF-A/Ang-2 Bispecific Antibody) in Patients with Diabetic Macular Edema 2022-08-08 08:00
Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant 2022-08-08 07:55
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy 2022-08-07 07:00
BGI's Global Life Science Research Leadership Recognized in 2022 Nature Index 2022-08-05 22:18
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms 2022-08-05 20:45
Yiling's Lianhua Health Products Well-received: CICPE 2022-08-05 15:54
1 121 122 123 124 125 414